Cerebral venous thrombosis is a rare but potentially life-threatening condition that is particularly prevalent in young women (ie, mean age 44 years) and accounts for 0·5–3% of all strokes. The ...

Ascletis Pharma’s rapid-fire expansion into obesity drug development has passed another milestone. | Ascletis Pharma’s ...

The evolution of 3D printing technology has opened up new avenues in the pharmaceutical industry, especially in the fabrication of novel drug delivery systems. One such advancement is the 3D printing ...

Following receipt of increasing peanut oral immunotherapy, or home-measured peanut butter, desensitization to peanut protein ...

PITTSBURGH - Lipella Pharmaceuticals Inc. (NASDAQ:LIPO), a biotech firm specializing in novel therapies for medical conditions lacking adequate treatments, has received FDA approval for an Expanded ...

The EAP will provide patients with oral lichen planus (OLP), a chronic ... Currently, LP-310 is undergoing a Phase 2a multicenter, dose-ranging clinical trial to assess its safety, tolerability ...

Other factors, including the specific diagnosis, age, and body weight, may affect your dosage of fluconazole. Fluconazole comes as an oral tablet. It’s usually taken once per day. There are ...

See reviews below to learn more or submit your own review. How do I know I can trust these reviews about National Credit Adjusters? How do I know I can trust these reviews about National Credit ...

Patients prescribed subcutaneous MTX were prescribed a higher dose of MTX (mean dose over first three ... MTX had changed treatment compared with 77% treated with oral MTX. After adjusting for ...

Original Medicare does not cover routine dental care or oral surgery for the general health of the teeth. However, Medicare may approve coverage for oral surgery in special cases. Although ...